Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL521 (Manorfen, Motrin ib, Rufen, Fenbid, Ibutime, Ibuprohm, Arthrofen 400, Junior strength ibuprofen, Orbifen, Nurofen back pain sr, Ibumed, Relcofen, Ibuprofenum, Isisfen, Nurofen sinus, Rimafen, Lidifen-f, Codafen continus, Proflex, Motrin, Pacifene, Brufen ret, Caldolor, Cuprofen plus, Advil, Apsifen, Co-op, Ibuderm, Children's ibuprofen, Femafen, RD 13621, IB-100, Ibumetin, Children's advil, Ibu-slo, Children's advil-flavored, Ibugel fte, Ibumousse, Phor pain, Apsifen-f, Nuprin, Advil liqui-gels, Ibuprofen, Ibugel, Ibuprin, Children's elixsure, Burana, Lidifen, Junior strength motrin, Nurofen child, Ibular, Cap-profen, Medipren, M01AE01, Seclodin, Phorpain max strgh, Anadin liquifast, Ibufac, Fenbid fte, Cuprofen for child, Arthrofen 200, U-18573, Profen, Nurofen for child, Ibu-tab 200, U-18,573, Nurofen solb, Deep relief, IP-82, Aches-n-pain, Feverfen, Anadin period pain relief, Phorpain, Children's motrin, NSC-256857, Advil migraine liqui-gels, Inoven, Ibuleve, Novaprin, Ibu-tab, Pedea, Ibuspray, Inabrin, Lobufen, Migrafen, Infant's advil, Motrin migraine pain, Ibucalm, Anadin joint pain, Pediatric advil, Maxa-gesic, Midol liquid gels, Arthrofen 600, Phensic, Nurofen 400, Junifen, Nurofen plus, Fleximex, Junior strength advil, Paxofen, Mandafen, Anadin ultra, Fenpaed, Tab-profen, Suspren, Ebufac, Nurofen recovery, Midol, Proflex sr) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
AKR1C3/Aldo-keto-reductase family 1 member C3 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4681] [GtoPdb: 1382] [UniProtKB: P42330] | ||||||||
ChEMBL | Inhibition of recombinant human AKR1C3 | B | 4.48 | pIC50 | 33000 | nM | IC50 | Bioorg. Med. Chem. Lett. (2005) 15: 5170-5175 [PMID:16183274] |
ChEMBL | Inhibition of AKR1C3 (unknown origin) | B | 5 | pIC50 | 10000 | nM | IC50 | MedChemComm (2018) 9: 969-981 [PMID:30108986] |
5-LOX/Arachidonate 5-lipoxygenase in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL215] [GtoPdb: 1385] [UniProtKB: P09917] | ||||||||
ChEMBL | Inhibitory activity against 5-lipoxygenase in Human whole blood (HWBL) stimulated with calcium ionophore (A23187) and LTB4 measured by enzyme immunoassay | F | 4.77 | pIC50 | 17000 | nM | IC50 | J. Med. Chem. (1997) 40: 819-824 [PMID:9057869] |
5-LOX/Arachidonate 5-lipoxygenase in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL312] [GtoPdb: 1385] [UniProtKB: P12527] | ||||||||
ChEMBL | Inhibition of 5-LOX in RBL1 cells assessed as reduction in LTB4 production using A23187-induced arachidonic acid as substrate preincubated for 2 hrs followed by A23187 addition measured after 15 mins by LC-MS/MS analysis | B | 4 | pIC50 | >100000 | nM | IC50 | ACS Med Chem Lett (2017) 8: 864-868 [PMID:28835803] |
ChEMBL | Inhibitory activity against 5-lipoxygenase catalysis (5-LO) in sonicated rat basophilic leukemia cell lysate | F | 4.85 | pIC50 | 14000 | nM | IC50 | J. Med. Chem. (1997) 40: 819-824 [PMID:9057869] |
COX-1 /Cyclooxygenase-1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL221] [GtoPdb: 1375] [UniProtKB: P23219] | ||||||||
ChEMBL | Inhibition of human recombinant COX1 expressed in Sf9 cells using arachidonic acid and ADHP incubated for 3 mins by fluorimetry | B | 4.47 | pIC50 | 34000 | nM | IC50 | J Med Chem (2020) 63: 12614-12622 [PMID:32931274] |
ChEMBL | Inhibition of PGHS1 assessed as conversion of arachidonic acid to prostaglandin | B | 4.6 | pIC50 | 25000 | nM | IC50 | J. Nat. Prod. (1999) 62: 294-296 [PMID:10075763] |
ChEMBL | Inhibition of COX1-catalyzed prostaglandin biosynthesis 10 mins of preincubation | B | 4.74 | pIC50 | 18000 | nM | IC50 | J. Nat. Prod. (1998) 61: 1212-1215 [PMID:9784154] |
ChEMBL | Inhibition activity against recombinant human Prostaglandin G/H synthase 1 | B | 4.95 | pIC50 | 11100 | nM | IC50 | J. Med. Chem. (1997) 40: 819-824 [PMID:9057869] |
ChEMBL | Inhibition of COX1 in human whole blood after 15 mins | B | 5.16 | pIC50 | 6900 | nM | IC50 | Bioorg. Med. Chem. (2007) 15: 4876-4890 [PMID:17517512] |
ChEMBL | Compound was evaluated for inhibition of Prostaglandin G/H synthase 1 | B | 5.2 | pIC50 | 6300 | nM | IC50 | Bioorg. Med. Chem. Lett. (1996) 6: 707-712 |
GtoPdb | - | - | 5.52 | pIC50 | 3000 | nM | IC50 | J Med Chem (1998) 41: 1124-37 [PMID:9544212] |
ChEMBL | Inhibition of Prostaglandin G/H synthase 1 (COX-1). | B | 5.52 | pIC50 | 3000 | nM | IC50 | J. Med. Chem. (1998) 41: 1124-1137 [PMID:9544212] |
ChEMBL | Concentration (in uM) to inhibit 50% of Prostaglandin G/H synthase 1 (COX-1) and is expressed in IC50. | B | 5.52 | pIC50 | 3000 | nM | IC50 | J. Med. Chem. (1998) 41: 1112-1123 [PMID:9544211] |
ChEMBL | Inhibitory activity against prostaglandin G/H synthase 1 (COX-1) | B | 5.52 | pIC50 | 3000 | nM | IC50 | J. Med. Chem. (1998) 41: 3515-3529 [PMID:9719605] |
ChEMBL | Inhibition of COX-1 (unknown origin) using arachidonic acid as substrate measured after 10 mins by fluorometric based multimode microplate reader | B | 5.57 | pIC50 | 2704 | nM | IC50 | Eur J Med Chem (2021) 209: 112918-112918 [PMID:33071054] |
ChEMBL | Inhibition of COX-1 in human washed platelet assessed as inhibition of 10 uM arachidonic acid-induced TXB2 formation incubated for 25 mins prior to arachidonic acid challenge measured after 30 mins by radioimmunoassay | B | 5.73 | pIC50 | 1860 | nM | IC50 | J. Med. Chem. (2013) 56: 4277-4299 [PMID:23651359] |
ChEMBL | Inhibition of COX-1 in human washed platelet assessed as inhibition of 0.5 uM arachidonic acid-induced TXB2 formation incubated for 25 mins prior to arachidonic acid challenge measured after 30 mins by radioimmunoassay | B | 6.54 | pIC50 | 290 | nM | IC50 | J. Med. Chem. (2013) 56: 4277-4299 [PMID:23651359] |
ChEMBL | DRUGMATRIX: Cyclooxygenase COX-1 enzyme inhibition (substrate: Arachidonic acid) | B | 6.67 | pIC50 | 212 | nM | IC50 | DrugMatrix in vitro pharmacology data |
Cyclooxygenase-1 in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2860] [UniProtKB: O62664] | ||||||||
ChEMBL | Inhibition of bovine seminal microsomal COX1 assessed as PGE2 production preincubated for 10 mins | B | 4.74 | pIC50 | 18000 | nM | IC50 | J. Nat. Prod. (1998) 61: 2-7 [PMID:9461646] |
ChEMBL | Inhibition of bovine seminal microsomal COX1 assessed as PGE2 production | B | 4.89 | pIC50 | 13000 | nM | IC50 | J. Nat. Prod. (1998) 61: 2-7 [PMID:9461646] |
ChEMBL | Inhibition of bovine COX1 by enzyme immunoassay | B | 5.54 | pIC50 | 2900 | nM | IC50 | J. Med. Chem. (2009) 52: 1525-1529 [PMID:19296694] |
ChEMBL | Inhibition of bovine COX-1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. Lett. (2009) 19: 6855-6861 [PMID:19884005] |
Cyclooxygenase-1 in Sheep (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2949] [UniProtKB: P05979] | ||||||||
ChEMBL | Inhibition of sheep placental cotyledons COX1 | B | 5.05 | pKi | 9000 | nM | Ki | J. Med. Chem. (2011) 54: 8555-8562 [PMID:22091869] |
ChEMBL | Inhibition of ovine COX1 using arachidonic acid as substrate pretreated for 3 mins followed by substrate addition measured immediately | B | 4.14 | pIC50 | 72800 | nM | IC50 | J Nat Prod (2017) 80: 2472-2477 [PMID:28885836] |
ChEMBL | Competitive inhibition of ovine COX-1 assessed as reduction in PGE2 production using 6250 nM arachidonic acid as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured after 20 mins by ELISA | B | 4.15 | pIC50 | 70100 | nM | IC50 | ACS Med Chem Lett (2021) 12: 610-616 [PMID:33854702] |
ChEMBL | Inhibition of ovine COX-1 assessed as decrease in PGH2 production using arachidonic acid as substrate treated with enzyme for 10 mins prior to substrate challenge for 2 mins by enzyme immunoassay | B | 4.59 | pIC50 | 26000 | nM | IC50 | Bioorg. Med. Chem. Lett. (2014) 24: 1958-1962 [PMID:24656662] |
ChEMBL | Inhibitory concentration against Prostaglandin G/H synthase 1 of ram seminal vesicles at 100 uM | B | 4.84 | pIC50 | 14400 | nM | IC50 | Bioorg. Med. Chem. Lett. (2005) 15: 1793-1797 [PMID:15780608] |
ChEMBL | Inhibition of ovine COX-1 assessed as residual activity by measuring formation of 12-HHT from arachidonic acid by HPLC analysis | B | 4.92 | pIC50 | 12000 | nM | IC50 | Bioorg. Med. Chem. (2011) 19: 5372-5382 [PMID:21873070] |
ChEMBL | Inhibition of ovine COX1 after 5 mins | B | 4.92 | pIC50 | 12000 | nM | IC50 | J. Med. Chem. (2010) 53: 4691-4700 [PMID:20503989] |
ChEMBL | Inhibition of purified ovine COX1 pre-treated for 1 hr before 10-acetyl-3,7-dihydroxyphenoxazin substrate addition in absence of porcine liver esterase by fluorescence assay | B | 5 | pIC50 | 10100 | nM | IC50 | ACS Med. Chem. Lett. (2014) 5: 983-988 [PMID:25221653] |
ChEMBL | Inhibition of Ovine COX-1 preincubated for 15 mins by fluorescence analysis | B | 5 | pIC50 | >10000 | nM | IC50 | ACS Med. Chem. Lett. (2015) 6: 1086-1090 [PMID:26487917] |
ChEMBL | Tested for inhibitory activity against Prostaglandin G/H synthase 1 from ovine | B | 5.05 | pIC50 | 9000 | nM | IC50 | J. Med. Chem. (1995) 38: 3895-3901 [PMID:7562922] |
ChEMBL | Inhibition of ram seminal vesicle COX1 assessed as reduction in PGE2 formation pre-incubated for 5 mins before arachidonic acid addition and measured after 20 mins by ELISA | B | 5.2 | pIC50 | 6300 | nM | IC50 | J Nat Prod (2017) 80: 999-1006 [PMID:28322565] |
ChEMBL | Inhibition of ovine COX1 pre-incubated for 10 mins before arachidonic acid substrate addition by enzyme immunoassay | B | 5.3 | pIC50 | 5000 | nM | IC50 | J. Med. Chem. (2012) 55: 8807-8826 [PMID:23043222] |
ChEMBL | Inhibition of ovine COX1 using arachidonic acid as substrate pretreated for 5 mins followed by substrate addition and measured after 2 mins by fluorescence based enzyme immunoassay | B | 5.39 | pIC50 | 4120 | nM | IC50 | Eur J Med Chem (2019) 180: 86-98 [PMID:31301566] |
ChEMBL | Inhibition of ovine COX-1 | B | 5.4 | pIC50 | 4000 | nM | IC50 | J. Med. Chem. (2011) 54: 1356-1364 [PMID:21280601] |
ChEMBL | Competitive inhibition of ovine COX-1 assessed as reduction in PGE2 production using 250 nM arachidonic acid as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured after 20 mins by ELISA | B | 5.4 | pIC50 | 4000 | nM | IC50 | ACS Med Chem Lett (2021) 12: 610-616 [PMID:33854702] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. Lett. (2011) 21: 6074-6080 [PMID:21890358] |
ChEMBL | Inhibition of ovine COX1 | B | 5.54 | pIC50 | 2900 | nM | IC50 | J. Med. Chem. (2012) 55: 688-696 [PMID:22148253] |
ChEMBL | Inhibition of ovine COX1 | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. Lett. (2013) 23: 163-168 [PMID:23200247] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. (2007) 15: 4767-4774 [PMID:17509888] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. Lett. (2016) 26: 406-412 [PMID:26691756] |
ChEMBL | In vitro inhibitory concentration against COX-1 enzyme | B | 5.54 | pIC50 | 2900 | nM | IC50 | J. Med. Chem. (2005) 48: 4061-4067 [PMID:15943479] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. (2008) 16: 9694-9698 [PMID:18930406] |
ChEMBL | Inhibition of ovine COX1 by enzyme immunoassay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. Lett. (2009) 19: 3014-3018 [PMID:19419861] |
ChEMBL | Inhibition of ovine COX1 by enzyme immunoassay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. (2009) 17: 5182-5188 [PMID:19500994] |
ChEMBL | Inhibition of ovine COX1 by enzyme immunoassay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. Lett. (2010) 20: 1324-1329 [PMID:20097072] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. Lett. (2010) 20: 896-902 [PMID:20045320] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. Lett. (2010) 20: 2168-2173 [PMID:20202839] |
ChEMBL | Inhibition of sheep COX1 by enzyme immunoassay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. Lett. (2010) 20: 4544-4549 [PMID:20576432] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. Lett. (2011) 21: 3951-3956 [PMID:21641217] |
ChEMBL | Inhibition of ovine COX1 by enzyme immuno assay | B | 5.54 | pIC50 | 2900 | nM | IC50 | Bioorg. Med. Chem. Lett. (2009) 19: 584-588 [PMID:19136259] |
ChEMBL | Inhibition of ovine COX-1 assessed as reduction in PGE2 production using 10 uM arachidonic acid as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured after 20 mins by ELISA | B | 5.66 | pIC50 | 2190 | nM | IC50 | ACS Med Chem Lett (2021) 12: 610-616 [PMID:33854702] |
ChEMBL | Inhibition of ovine COX1 assessed as reduction in Prostaglandin production by enzyme immunoassay | B | 5.85 | pIC50 | 1420 | nM | IC50 | Bioorg Med Chem (2018) 26: 891-902 [PMID:29373271] |
ChEMBL | Reversible competitive inhibition of prostaglandin G/H synthase 1 | B | 5.97 | pIC50 | 1060 | nM | IC50 | Bioorg. Med. Chem. Lett. (2004) 14: 667-671 [PMID:14741265] |
COX-2 /Cyclooxygenase-2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL230] [GtoPdb: 1376] [UniProtKB: P35354] | ||||||||
ChEMBL | Inhibition of human recombinant COX-2 assessed as residual activity by measuring formation of 12-HHT from arachidonic acid by HPLC analysis | B | 4.1 | pIC50 | 80000 | nM | IC50 | Bioorg. Med. Chem. (2011) 19: 5372-5382 [PMID:21873070] |
ChEMBL | Inhibition of human recombinant COX2 after 5 mins | B | 4.1 | pIC50 | 80000 | nM | IC50 | J. Med. Chem. (2010) 53: 4691-4700 [PMID:20503989] |
ChEMBL | Inhibition of human COX2 pre-incubated for 10 mins before substrate addition by enzyme immunoassay | B | 4.44 | pIC50 | 36000 | nM | IC50 | J. Med. Chem. (2012) 55: 8807-8826 [PMID:23043222] |
ChEMBL | Inhibitory activity against prostaglandin G/H synthase 2 (COX-2) | B | 4.52 | pIC50 | 30000 | nM | IC50 | J. Med. Chem. (1998) 41: 3515-3529 [PMID:9719605] |
ChEMBL | Concentration (in uM) to inhibit 50% of Prostaglandin G/H synthase 2 (COX-2) and is expressed in IC50. | B | 4.52 | pIC50 | 30000 | nM | IC50 | J. Med. Chem. (1998) 41: 1112-1123 [PMID:9544211] |
ChEMBL | Inhibition of Prostaglandin G/H synthase 2 (COX-2). | B | 4.52 | pIC50 | 30000 | nM | IC50 | J. Med. Chem. (1998) 41: 1124-1137 [PMID:9544212] |
ChEMBL | Inhibition of human recombinant COX-2 assessed as decrease in PGH2 production using arachidonic acid as substrate treated with enzyme for 10 mins prior to substrate challenge for 2 mins by enzyme immunoassay | B | 4.52 | pIC50 | 30000 | nM | IC50 | Bioorg. Med. Chem. Lett. (2014) 24: 1958-1962 [PMID:24656662] |
ChEMBL | DRUGMATRIX: Cyclooxygenase COX-2 enzyme inhibition (substrate: Arachidonic acid) | B | 4.59 | pIC50 | 25530 | nM | IC50 | DrugMatrix in vitro pharmacology data |
ChEMBL | Inhibition of COX2 (unknown origin) | B | 4.84 | pIC50 | 14500 | nM | IC50 | Eur J Med Chem (2017) 138: 1002-1033 [PMID:28759875] |
ChEMBL | Inhibition of recombinant human COX2 using arachidonic acid as substrate pretreated for 5 mins followed by substrate addition and measured after 2 mins by fluorescence based enzyme immunoassay | B | 5.05 | pIC50 | 8910 | nM | IC50 | Eur J Med Chem (2019) 180: 86-98 [PMID:31301566] |
ChEMBL | Tested for inhibitory activity against Prostaglandin G/H synthase 2 from human | B | 5.1 | pIC50 | 8000 | nM | IC50 | J. Med. Chem. (1995) 38: 3895-3901 [PMID:7562922] |
ChEMBL | Inhibition of COX2 in human whole blood after 15 mins | B | 5.21 | pIC50 | 6200 | nM | IC50 | Bioorg. Med. Chem. (2007) 15: 4876-4890 [PMID:17517512] |
ChEMBL | Inhibition of COX-2 (unknown origin) using arachidonic acid as substrate measured after 10 mins by fluorometric based multimode microplate reader | B | 5.27 | pIC50 | 5326 | nM | IC50 | Eur J Med Chem (2021) 209: 112918-112918 [PMID:33071054] |
ChEMBL | Inhibition of human recombinant COX2 pre-treated for 1 hr before 10-acetyl-3,7-dihydroxyphenoxazin substrate addition in absence of porcine liver esterase by fluorescence assay | B | 5.37 | pIC50 | 4300 | nM | IC50 | ACS Med. Chem. Lett. (2014) 5: 983-988 [PMID:25221653] |
ChEMBL | Inhibition of human recombinant COX2 assessed as reduction in PGE2 formation pre-incubated for 5 mins before arachidonic acid addition and measured after 20 mins by ELISA | B | 5.38 | pIC50 | 4200 | nM | IC50 | J Nat Prod (2017) 80: 999-1006 [PMID:28322565] |
ChEMBL | Inhibition of human recombinant COX-2 assessed as reduction in PGE2 production using 10 uM arachidonic acid as substrate preincubated with enzyme for 5 mins followed by substrate addition and measured after 20 mins by ELISA | B | 5.48 | pIC50 | 3300 | nM | IC50 | ACS Med Chem Lett (2021) 12: 610-616 [PMID:33854702] |
ChEMBL | Inhibition of human recombinant COX2 expressed in Sf9 cells using arachidonic acid and ADHP incubated for 5 mins by fluorimetry | B | 5.48 | pIC50 | 3300 | nM | IC50 | J Med Chem (2020) 63: 12614-12622 [PMID:32931274] |
ChEMBL | Inhibition of human recombinant COX2 assessed as reduction in PGE2 production using arachidonic acid substrate by ELISA | B | 5.7 | pIC50 | 2000 | nM | IC50 | J Nat Prod (2019) 82: 1839-1848 [PMID:31268709] |
ChEMBL | Inhibition of human recombinant COX-2 | B | 5.85 | pIC50 | 1400 | nM | IC50 | J. Med. Chem. (2011) 54: 1356-1364 [PMID:21280601] |
ChEMBL | Inhibition of human COX2 expressed in baculovirus system | B | 5.87 | pIC50 | 1350 | nM | IC50 | J. Med. Chem. (2011) 54: 8555-8562 [PMID:22091869] |
GtoPdb | - | - | 5.87 | pIC50 | 1350 | nM | IC50 | J Med Chem (2011) 54: 8555-62 [PMID:22091869] |
ChEMBL | Inhibition of human recombinant COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. Lett. (2016) 26: 406-412 [PMID:26691756] |
ChEMBL | Inhibition of human recombinant COX2 by enzyme immunoassay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. (2009) 17: 5182-5188 [PMID:19500994] |
ChEMBL | Inhibition of human recombinant COX-2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. Lett. (2009) 19: 6855-6861 [PMID:19884005] |
ChEMBL | Inhibition of human recombinant COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. Lett. (2011) 21: 3951-3956 [PMID:21641217] |
ChEMBL | Inhibition of human COX2 by enzyme immunoassay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. Lett. (2010) 20: 4544-4549 [PMID:20576432] |
ChEMBL | Inhibition of human recombinant COX2 | B | 5.96 | pIC50 | 1100 | nM | IC50 | J. Med. Chem. (2012) 55: 688-696 [PMID:22148253] |
ChEMBL | Inhibition of human recombinant COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. Lett. (2010) 20: 2168-2173 [PMID:20202839] |
ChEMBL | Inhibition of human recombinant COX2 | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. Lett. (2013) 23: 163-168 [PMID:23200247] |
ChEMBL | Inhibition of human recombinant COX2 by enzyme immunoassay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. Lett. (2010) 20: 1324-1329 [PMID:20097072] |
ChEMBL | Inhibition of recombinant human COX-2 preincubated for 15 mins by fluorescence analysis | B | 5.96 | pIC50 | 1100 | nM | IC50 | ACS Med. Chem. Lett. (2015) 6: 1086-1090 [PMID:26487917] |
ChEMBL | Inhibition of recombinant human N-terminal His-tagged COX2 expressed in baculovirus infected Sf21 cells assessed as reduction in prostaglandin production by enzyme immunoassay | B | 5.97 | pIC50 | 1080 | nM | IC50 | Bioorg Med Chem (2018) 26: 891-902 [PMID:29373271] |
ChEMBL | Inhibition activity against recombinant human Prostaglandin G/H synthase 2 | B | 7 | pIC50 | 100 | nM | IC50 | J. Med. Chem. (1997) 40: 819-824 [PMID:9057869] |
Cyclooxygenase-2 in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3331] [UniProtKB: O62698] | ||||||||
ChEMBL | Inhibition of bovine COX2 by enzyme immunoassay | B | 5.96 | pIC50 | 1100 | nM | IC50 | J. Med. Chem. (2009) 52: 1525-1529 [PMID:19296694] |
Cyclooxygenase-2 in Sheep (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4102] [UniProtKB: P79208] | ||||||||
ChEMBL | Inhibition of sheep placental cotyledons COX2 | B | 5.05 | pKi | 9000 | nM | Ki | J. Med. Chem. (2011) 54: 8555-8562 [PMID:22091869] |
ChEMBL | Inhibition of ovine COX2 assessed as reduction in PGH2 production by enzyme immunoassay | B | 5.85 | pIC50 | 1400 | nM | IC50 | Bioorg Med Chem (2018) 26: 4113-4126 [PMID:29980364] |
ChEMBL | Inhibition of ovine COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. (2007) 15: 4767-4774 [PMID:17509888] |
ChEMBL | Inhibition of ovine COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. (2008) 16: 9694-9698 [PMID:18930406] |
ChEMBL | Inhibition of ovine COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. Lett. (2009) 19: 584-588 [PMID:19136259] |
ChEMBL | In vitro inhibitory concentration against COX-2 enzyme | B | 5.96 | pIC50 | 1100 | nM | IC50 | J. Med. Chem. (2005) 48: 4061-4067 [PMID:15943479] |
ChEMBL | Inhibition of ovine COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. Lett. (2010) 20: 896-902 [PMID:20045320] |
ChEMBL | Inhibition of ovine COX2 by enzyme immuno assay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. Lett. (2011) 21: 6074-6080 [PMID:21890358] |
ChEMBL | Inhibition of ovine COX2 by enzyme immunoassay | B | 5.96 | pIC50 | 1100 | nM | IC50 | Bioorg. Med. Chem. Lett. (2009) 19: 3014-3018 [PMID:19419861] |
COX-2 /Cyclooxygenase-2 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4321] [GtoPdb: 1376] [UniProtKB: Q05769] | ||||||||
ChEMBL | Inhibition of COX-2 in mouse RAW264.7 cells assessed as decrease in LPS-induced PGE2 production treated prior to LPS challenge by enzyme immunoassay | B | 6.07 | pIC50 | 860 | nM | IC50 | Bioorg. Med. Chem. Lett. (2014) 24: 1958-1962 [PMID:24656662] |
Dehydrogenase/reductase SDR family member 9 in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075220] [UniProtKB: Q8VD48] | ||||||||
ChEMBL | Inhibition of rat liver 3-alpha-HSD assessed as 5-beta-dihydrocortisone reduction | B | 4 | pIC50 | 100000 | nM | IC50 | Bioorg. Med. Chem. (2007) 15: 4876-4890 [PMID:17517512] |
epidermal growth factor receptor/Epidermal growth factor receptor erbB1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL203] [GtoPdb: 1797] [UniProtKB: P00533] | ||||||||
ChEMBL | Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis | B | 5 | pIC50 | >10000 | nM | IC50 | ACS Med. Chem. Lett. (2015) 6: 1086-1090 [PMID:26487917] |
fatty acid binding protein 1/Fatty acid-binding protein, liver in Rat (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5738] [GtoPdb: 2531] [UniProtKB: P02692] | ||||||||
ChEMBL | Displacement of 1-anilinonaphthalene-8-sulphonic acid from rat recombinant L-FABP high binding affinity site expressed in Escherichia coli BL21 by competitive fluorescence displacement assay | B | 4.32 | pKi | 47600 | nM | Ki | J. Med. Chem. (2008) 51: 3755-3764 [PMID:18533710] |
L-PGDS/Prostaglandin-H2 D-isomerase in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4334] [GtoPdb: 1380] [UniProtKB: O09114] | ||||||||
ChEMBL | Concentration required to inhibit 50% activity of prostaglandin synthetase was determined in vitro in mouse brain microsomes | B | 4.89 | pIC50 | 13000 | nM | IC50 | J. Med. Chem. (1991) 34: 1099-1110 [PMID:1900533] |
Serum albumin in Bovine (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3728] [UniProtKB: P02769] | ||||||||
ChEMBL | Binding affinity to bovine serum albumin | B | 5.52 | pIC50 | 3000 | nM | IC50 | Bioorg. Med. Chem. (2008) 16: 1162-1173 [PMID:18024138] |
OAT6/Solute carrier family 22 member 20 in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL5269] [GtoPdb: 1037] [UniProtKB: Q80UJ1] | ||||||||
ChEMBL | Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr | B | 5.95 | pKi | 1122.02 | nM | Ki | J. Biol. Chem. (2007) 282: 23841-23853 [PMID:17553798] |
ChEMBL | Inhibition of mouse Oat6-mediated [3H]ES uptake in Xenopus oocytes after 1 hr | B | 5.96 | pKi |